| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |